Stay updated on LANRA + Gilteritinib in FLT3+ R/R AML Clinical Trial

Sign up to get notified when there's something new on the LANRA + Gilteritinib in FLT3+ R/R AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LANRA + Gilteritinib in FLT3+ R/R AML Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The site footer now identifies the website revision as v3.8.0 instead of v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-31T14:30:03.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    A site-wide NIH notice was added, announcing a transition from “Artificial Intelligence” to “Super Intelligence” terminology and linking to updates and FAQs.
    Difference
    0.5%
    Check dated 2026-10-24T16:49:22.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer now identifies the ClinicalTrials.gov site as running revision v3.7.2 instead of v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-17T16:37:12.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision number changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-10T16:40:24.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 was added to the record history and the older revision v3.6.6 was removed, indicating the page has been updated to reflect a newer version of the study record.
    Difference
    0.1%
    Check dated 2026-09-19T19:25:50.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    A new revision entry v3.6.6 was added to the study history, and the previous revision v3.6.5 was removed from the current history.
    Difference
    0.1%
    Check dated 2026-08-29T19:42:22.000Z thumbnail image

Stay in the know with updates to LANRA + Gilteritinib in FLT3+ R/R AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LANRA + Gilteritinib in FLT3+ R/R AML Clinical Trial page.